About Mylab
Mylab is a company based in Pune (India) founded in 2016 by Hasmukh Rawal and Shailendra Balasaheb Kawade. The company has 437 employees as of April 05, 2024. Mylab has completed 2 acquisitions, including Swayam and sanskritech.com. Mylab offers products and services including PathoDetect, NATSpert, OncoScreen, and AgroDex. Mylab operates in a competitive market with competitors including Natera, ArcherDX, Inflammatix, MeMed and Variantyx, among others.
- Headquarter Pune, India
- Employees 437 as on 05 Apr, 2024
- Founders Hasmukh Rawal, Shailendra Balasaheb Kawade
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mylab Discovery Solutions Pvt. Ltd.
- Jurisdiction Lonawala, Maharashtra, India
-
Annual Revenue
$32.64 M (USD)0as on Mar 31, 2022
-
Net Profit
$1.92 M (USD)0as on Mar 31, 2022
-
EBITDA
$3.63 M (USD)0as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Zydus Life
& 4 more
-
Employee Count
437
as on Apr 05, 2024
-
Investments & Acquisitions
Swayam
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mylab
Mylab offers a comprehensive portfolio of products and services, including PathoDetect, NATSpert, OncoScreen, and AgroDex.
Kit for pathogen detection in food and clinical samples
System for viral nucleic acid extraction and amplification
Kits for mutation detection in tumor samples
Kit for identifying GMO in raw food materials
People of Mylab
Unlock access to complete
Funding Insights of Mylab
Investors in Mylab
Mylab has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Zydus Life, ACT Grants and Adar Poonawalla.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed capital grants are provided to incubate and accelerate innovations.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Manufacturer of pharmaceutical products, including formulations, APIs, vaccines, and biosimilars
|
Locked | Locked | Locked |
Investor details for Mylab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mylab
Mylab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Swayam and sanskritech.com.
Investment portfolio details for Mylab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of health monitoring kiosk
|
Locked | Locked | 2018 | Locked | |
|
Limited information is available on core activities of the company.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Mylab
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Mylab
Detailed financials for Mylab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mylab Comparisons
Peer comparison for Mylab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mylab
Mylab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, ArcherDX, Inflammatix, MeMed and Variantyx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
Detailed competitors of Mylab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mylab
Complete news archive for Mylab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mylab
Mylab was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Mylab is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Rahul Patil is the current CEO of Mylab.
As of Apr 05, 2024, the latest employee count at Mylab is 437.
Annual revenue of Mylab is $32.64M as on Mar 31, 2022.
Mylab was founded in 2016 in Pune, India, within the diagnostics sector. Diagnostic kits are developed for pathogen detection and viral load monitoring, targeting infections, cancer, genetic disorders, and blood screening. Automated systems are offered, including Compact x for integrated sample preparation, assay setup, and detection; Compact xL as a sample-to-PCR ready platform; and CompactQ for fluorescence quantitative PCR analysis. Operations focus on healthcare applications in the region.
Mylab's top competitors include Natera, Inflammatix and MeMed.
Mylab offers PathoDetect, NATSpert, OncoScreen, and AgroDex.
Mylab has made 2 acquisitions, including Swayam, and sanskritech.com.
Mylab has 5 investors. Key investors include Zydus Life, ACT Grants, Adar Poonawalla, Abhijit Pawar, and Rising Sun Holdings.